Overview
Durga Kanigicherla practices in Manchester, United Kingdom. Kanigicherla is rated as an Elite expert by MediFind in the treatment of Membranous Nephropathy. Their top areas of expertise are Membranous Nephropathy, Glomerulonephritis, Nephrotic Syndrome, Chronic Kidney Disease, and Kidney Transplant.
Their clinical research consists of co-authoring 26 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 19 articles in the study of Membranous Nephropathy.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Membranous NephropathyKanigicherla isElite. Learn about Membranous Nephropathy.
- Distinguished
- GlomerulonephritisKanigicherla isDistinguished. Learn about Glomerulonephritis.
- Advanced
- Nephrotic SyndromeKanigicherla isAdvanced. Learn about Nephrotic Syndrome.
- Experienced
- Chronic Kidney DiseaseKanigicherla isExperienced. Learn about Chronic Kidney Disease.
- Focal Segmental GlomerulosclerosisKanigicherla isExperienced. Learn about Focal Segmental Glomerulosclerosis.
- Interstitial NephritisKanigicherla isExperienced. Learn about Interstitial Nephritis.
- Kidney TransplantKanigicherla isExperienced. Learn about Kidney Transplant.
- Lacrimal Gland TumorKanigicherla isExperienced. Learn about Lacrimal Gland Tumor.
- Minimal Change DiseaseKanigicherla isExperienced. Learn about Minimal Change Disease.